← Back to provider comparison

Provider profile · source-bound facts

Pallas Health – GLP-1 Weight Loss & NAD

People comparing a clinician-led GLP-1 program with published introductory and 12-week prices

Get startedRead editorial evidence
Original editorial evidence scene for the Pallas Health – GLP-1 Weight Loss & NAD provider profile

Medication and plan pricing

Treatments

Dates, quotes, doses, and source links stay attached to every displayed amount. A dose without a published price stays “Not published”.

Monthly

Compounded semaglutide (injection)

$199/monthChecked
Price source
Compounded semaglutide is $ 139 for your first month, then $ 597 every 12 weeks ($ 199 /mo average); compounded tirzepatide is $ 179 first month, then $ 897 every 12 weeks ($ 299 /mo average).
Open the provider page

$139 published first-month rate · then $199/month

Same price at every published dose

Dose-level price check. An explicit first-party quote connects one price to every/all/same/regardless-of-dose; every canonical ladder dose may carry that exact evidenced price.

Evidence current as of · dose-pricing source
  • mg/week$ / month
  • 0.25 mg/week$199/month
  • 0.5 mg/week$199/month
  • 1 mg/week$199/month
  • 1.7 mg/week$199/month
  • 2.4 mg/week$199/month
Monthly

Compounded tirzepatide (injection)

$299/monthChecked
Price source
Compounded semaglutide is $ 139 for your first month, then $ 597 every 12 weeks ($ 199 /mo average); compounded tirzepatide is $ 179 first month, then $ 897 every 12 weeks ($ 299 /mo average).
Open the provider page

$179 published first-month rate · then $299/month

Same price at every published dose

Dose-level price check. An explicit first-party quote connects one price to every/all/same/regardless-of-dose; every canonical ladder dose may carry that exact evidenced price.

Evidence current as of · dose-pricing source
  • mg/week$ / month
  • 2.5 mg/week$299/month
  • 5 mg/week$299/month
  • 7.5 mg/week$299/month
  • 10 mg/week$299/month
  • 12.5 mg/week$299/month
  • 15 mg/week$299/month

At a glance

Unknown is kept separate from a verified negative.

Medication paths

Compounded semaglutide and tirzepatide injections; Wegovy is also named in program materials

Insurance

Cash-pay pricing is published; insurance coverage is not represented here.

State evidence

The captured public page does not publish a complete state list.

View state evidence source (partner portal — not publicly viewable) · current as of 2026-08-16

Editorial tradeoffs

Useful for comparing: People comparing a clinician-led GLP-1 program with published introductory and 12-week prices

Limitations in the record

  • Later 12-week pricing is higher than the introductory month
  • A complete state list is not published on the captured page
  • Compounded drugs are not FDA approved

Feature evidence and unknowns

Free shipping is advertised; no exact delivery window is published.

The page identifies compounded semaglutide and tirzepatide but does not publish a 503A or 503B pharmacy designation.

Clinic Scout patient reviews

Share your experience for moderation

No Clinic Scout patient reviews are published for this provider. Submissions go through manual moderation before anything appears here.

Methodology and evidence boundary

Provider identity comes from the governed registry. Prices come from the dated provider pricing matrix. Program facts come from the content ledger. Clinic Scout does not infer availability, medical fit, ratings, or review counts.

Affiliate and ranking methodology

Still have questions? Read the research library or email us at [email protected].